Common crossroads in diabetes management
Open Access
- 1 January 2008
- journal article
- Published by Springer Science and Business Media LLC in Osteopathic Medicine and Primary Care
- Vol. 2 (1), 4
- https://doi.org/10.1186/1750-4732-2-4
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- ExenatideCardiology in Review, 2006
- Inhaled Human Insulin (Exubera??)Drugs, 2006
- Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trialThe Lancet, 2005
- Insulin infusion in acute illnessJCI Insight, 2005
- The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysisDiabetologia, 2005
- A Critical Appraisal of the Role of Insulin Analogues in the Management of Diabetes MellitusDrugs, 2005
- Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Sulfonylurea-Treated Patients With Type 2 DiabetesDiabetes Care, 2004
- Safety and efficacy of insulin glargine (HOE 901) versus NPH insulin in combination with oral treatment in Type 2 diabetic patientsDiabetic Medicine, 2003
- Influences on day-to-day self-management of type 2 diabetes among African-American women: spirituality, the multi-caregiver role, and other social context factors.Diabetes Care, 2000
- Effect of intensive diabetes management on macrovascular events and risk factors in the diabetes control and complications trialThe American Journal of Cardiology, 1995